HELPING PEOPLE LIVE BETTER

Every day, our medicines help 64 million people in emerging countries live better, fuller and healthier lives


OUR MEDICINES BUSINESS
banner-image

Abbott is the only global healthcare company with a pharmaceuticals business entirely dedicated to emerging markets. Operating in 95 countries, we bring trusted care where it’s needed most, helping people live healthier lives through our life-changing technologies and products.

Whether it is an ordinary headache or a more serious illness, we want people to get better fast, so they can go back to doing the things they love.

We’ve delivered high-quality healthcare for the last 135 years and are committed to continuing to do so in the future.

Worldwide

EXPANDING ACCESS TO HEALTH
banner-image

At Abbott, we believe that the best healthcare solutions are those that reach the people who need them most. With our medicines business focused on emerging countries, we are committed to making high-quality treatments more accessible, improving health outcomes where it matters most.

Our growing biosimilars portfolio is helping expand access to life-changing biologic medicines in areas like oncology, immunology, and women’s health—bringing the latest medical innovations to more people, so they can live healthier, fuller lives.

Biosimilars
  • QUALITY AND TRUST

    We hold ourselves to the highest standards of quality, with rigorous processes that reflect our commitment to safety and reliability. We have delivered high-quality healthcare for the last 135+ years, and we are committed to continuing to do so in the future.

    Our commitment
  • TRUSTED PRODUCTS

    Our portfolio includes over 1,500 lifesaving and life-changing products that help millions of people every day, from headache treatments, flu vaccines to cutting-edge biosimilars for cancer, immunology and women’s health.

    Our products
  • INSIGHT-DRIVEN INNOVATION

    With our innovations, technologies and differentiated medicines, we aim to transform the way people in emerging countries take medicines. In addition to incremental innovation that makes medicines better, we leverage strategic partnerships and co-development for lasting impact.

GLO2303431